Serum can supply 6 lakh Covishield to Sri Lanka if purchased for $15 per dose | The Business Standard
Skip to main content
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Sunday
June 29, 2025

Sign In
Subscribe
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
SUNDAY, JUNE 29, 2025
Serum can supply 6 lakh Covishield to Sri Lanka if purchased for $15 per dose

Coronavirus chronicle

TBS Report
29 May, 2021, 09:25 am
Last modified: 29 May, 2021, 09:30 am

Related News

  • Sri Lanka keen to strengthen relations with Bangladesh's private sector
  • Sri Lanka seeks Bangladesh investment for pharma industry development
  • Sri Lanka train kills elephant despite new safety moves
  • Walton expands footprint in Sri Lanka
  • 21 killed as bus carrying pilgrims crashes in Sri Lanka

Serum can supply 6 lakh Covishield to Sri Lanka if purchased for $15 per dose

The Oxford-authorised Indian vaccine manufacturer had previously supplied the Covishield vaccine to Sri Lanka for only US$05 per dose

TBS Report
29 May, 2021, 09:25 am
Last modified: 29 May, 2021, 09:30 am
A healthcare worker prepares to administer a dose of the Oxford University-AstraZeneca vaccine, marketed by the Serum Institute of India (SII) as COVISHIELD, against the coronavirus disease (COVID-19), in Santiago, Dominican Republic February 17, 2021. REUTERS/Ricardo Rojas/File Photo
A healthcare worker prepares to administer a dose of the Oxford University-AstraZeneca vaccine, marketed by the Serum Institute of India (SII) as COVISHIELD, against the coronavirus disease (COVID-19), in Santiago, Dominican Republic February 17, 2021. REUTERS/Ricardo Rojas/File Photo

Sri Lanka can get supply of Oxford AstraZeneca from the Indian vaccine manufacturer Serum if a dose is purchased for US$15.

Under this condition the company will be able to deliver six lakh doses of the vaccine within two weeks, reports Lanka News.

The Oxford-authorised Indian vaccine manufacturer had previously supplied the Covishield vaccine to Sri Lanka for only US$05 per dose. However, the neighbour country was unable to continue the supply in the recent event that the pandemic had struck hard on the land.

The Business Standard Google News Keep updated, follow The Business Standard's Google news channel

In the event that about six hundred thousand people in Sri Lanka administered with the first dose of the India-made Oxford AstraZeneca vaccine are in need of the second dose, the government of Sri Lanka had requested Serum to supply them more doses for US$10 per dose. In response, the company had informed the Sri Lankan authorities that it can continue the supply for US$15 per dose.

The second dose of the AstraZeneca vaccine should be administered within sixteen weeks since the first dose. Failure, the immunity required to battle the virus may not be developed within the body, experts point out.

Top News / World+Biz

Sri Lanka / Serum / Covishield

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Return to work or face stern action, govt warns protesters as NBR jobs declared 'essential services'
    Return to work or face stern action, govt warns protesters as NBR jobs declared 'essential services'
  • ACC officials hold a press briefing in Dhaka on 29 June 2025. Photo: TBS
    ACC launches inquiry against 6 NBR officials over corruption, nepotism allegations
  • Finance Adviser Dr Salehuddin Ahmed. Photo: Collected
    No meeting with NBR officials today: Finance adviser

MOST VIEWED

  • Biman Bangladesh bans WhatsApp for official use
    Biman Bangladesh bans WhatsApp for official use
  • How ONE Bank hides Tk995cr loss through provision deferral
    How ONE Bank hides Tk995cr loss through provision deferral
  • File photo of containers at Chattogram port/TBS
    Complete NBR shutdown halts customs operations, Chattogram Port paralysed
  • Infograph: TBS
    How banks made record profits in a depressed year
  • A battery-operated three-wheeled e-rickshaw on display at the inauguration ceremony of a driver training programme at the Dhaka North City Corporation auditorium on 28 June 2025. Photo: TBS
    E-rickshaws to be introduced in Uttara, Dhanmondi, Paltan areas in August
  • File photo of Umama Fatema/Collected
    'All of us were only deceived': Umama Fatema steps down from Students Against Discrimination

Related News

  • Sri Lanka keen to strengthen relations with Bangladesh's private sector
  • Sri Lanka seeks Bangladesh investment for pharma industry development
  • Sri Lanka train kills elephant despite new safety moves
  • Walton expands footprint in Sri Lanka
  • 21 killed as bus carrying pilgrims crashes in Sri Lanka

Features

Photo: Collected

Innovative storage accessories you’ll love

3h | Brands
Two competitors in this segment — one a flashy newcomer, the other a hybrid veteran — are going head-to-head: the GAC GS3 Emzoom and the Toyota CH-R. PHOTOS: Nafirul Haq (GAC Emzoom) and Akif Hamid (Toyota CH-R)

GAC Emzoom vs Toyota CH-R: The battle of tech vs trust

3h | Wheels
How a young man's commitment to nature in Tetulia won him a national award

How a young man's commitment to nature in Tetulia won him a national award

20h | Panorama
From blossoms to bounty: The mango season that revives Rajshahi

From blossoms to bounty: The mango season that revives Rajshahi

20h | Panorama

More Videos from TBS

What decisions were taken at the Advisory Council meeting?

What decisions were taken at the Advisory Council meeting?

35m | TBS Today
Why a well-intended NBR reform turned into a stand-off

Why a well-intended NBR reform turned into a stand-off

50m | TBS Insight
NBR activities declared 'essential service'

NBR activities declared 'essential service'

55m | TBS Today
Iran could again enrich uranium 'in few months': IAEA chief

Iran could again enrich uranium 'in few months': IAEA chief

1h | Videos
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net